Summary
A current hypothesis is that functional glucocerebrosidase needs to be delivered to the lysosomes of tissue macrophages to guarantee successful enzyme therapy for Gaucher's disease. In this study, biochemical and immunohistochemical techniques were applied to identify in mice the localization of intravenously administered alglucerase (human modified placental glucocerebrosidase). Only in liver and spleen was a significant increase of glucocerebrosidase activity observed, with a maximum level at 15 minutes after enzyme infusion. The uptake of enzyme by liver was sufficiently high to allow more detailed studies on the (sub)cellular distribution of human alglucerase. The enzyme in liver is localized both in the endosomallysosomal system of the Kupffer cells and the endothelial cells lining the lumen of the sinusoids. Uptake by both of these types of cell is prevented by mannan. The results suggest that the cellular mechanisms responsible for improvement of Gaucher patients receiving alglucerase treatment is probably more complicated than previously recognized.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
barneveld,r. a.,tegelaers,f. p.,ginns,e. i.,visser,p.,laanen,e. A.,brady,r. o.,galjaard,h.,barranger,j. a.,reuser,a. j. j. &tager,j. m. (1983a) Monoclonal antibodies against human betaglucocerebrosidase.Eur. J. Biochem. 134, 585–89.
barneveld,r. a.,keijzer,w.,tegelaers,f. p.,ginns,e. i.,geurts van kessel,a.,brady,r. o.,barranger,j. a.,tager,j. m.,galjaard,h.,westerveld,a. &reuser,a. J. J. (1983b) Assignment of the gene coding for human β-glucocerebrosidase to the region 921–q31 of chromosome 1 using monoclonal antibodies.Hum. Genet. 64, 227–31.
barranger,j. a. &ginns,e. i. (1989) Glucosylceramide lipidoses: Gaucher disease. InThe Metabolic Basis of Inherited Disease (edited byscriver,c. r. et al.), pp. 1677–98. New York: McGraw-Hill.
barton,n. w.,brady,r. o.,dambrosia,j. m. &dibisceglie,a. m. (1991) Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher disease.N. Engl. J. Med. 324, 1464–70.
beutler,e.,dale,g. l. &kuhl,w. (1980) Replacement therapy in Gaucher disease. InEnzyme Therapy in Genetic Diseases (edited bydesnick,r. j.) Vol. 2, pp. 369–81. New York: Alan R. Liss.
brady,r. o. (1984) Enzyme replacement in the sphingolipidoses. InMolecular Basis of Lysosomal Storage Disorders (edited bybarranger,j. a. &brady,r. o.), pp. 461–78. New York: Academic Press.
brady,r. o. &barton,n. w. (1994a) Enzyme replacement therapy for Gaucher disease: critical investigations beyond demonstration of clinical efficacy.Bioch. Med. Metab. Biol. 52, 1–9.
brady,r. o. &barton,n. w. (1994b) Development of effective enzyme therapy for metabolic storage disorders.Internat. Pediatrics 9, 175–80.
figueroa,m. l.,rosenbloom,b. e.,kay,a. g.,garver,p. g.,thurston,d. w.,koziol,j. a.,gelbart,t. &beutler,e. (1992) A less costly regimen of alglucerase to treat Gaucher's disease.N. Engl. J. Med. 327, 1632–6.
furbish,f. s.,steer,c. j.,barranger,j. a.,jones,e. a. &brady,r. o. (1978) The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells.Biochem. Biophys. Res. Commun. 81, 1047–53.
furbish,f. s.,steer,c. j.,krett,n. l. &barranger,j. a. (1981) Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effect of sequential deglycosylation.Biochim. Biophys. Acta 673, 425–34.
grabowski,g. a. (1993) Gaucher disease. Enzymology, genetics and treatment. InAdvances in Human Genetics (edited byharris,h. &hirschhorn,k.), pp. 377–441. New York: Plenum Press.
hoogeveen,a. t.,willemsen,r.,meyer,n.,derooij,k. E.,roos,r. a. C.,vanommen,g-j.b. &galjaard,h. (1993) Characterization and localization of the Huntington disease gene product.Hum. Molec. Genet. 12, 2069–73.
hubbard,a. l.,wilson,g.,ashwell,g. &stukenbrok,h. (1979) An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of125I-ligands among the liver cell types.J. Cell Biol. 83, 47–64.
morrone,s.,pentchev,p. g.,baynes,j. &thorpe,s. (1981) Studies in vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat.Biochem. J. 194, 733–42.
pontow,s. e.,kery,v. &stahl,p. d. (1992) Mannose receptor.Int. Rev. Cytol. 137B, 221–44.
sato,y. &beutler,e. (1993) Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.J. Clin. Invest. 91, 1909–17.
willemsen,r.,vandongen,j. m.,ginns,e. i.,sips,h. J.,schram,a. W.,tager,j. m.,barranger,j. a. &reuser,a. j. J. (1987) Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry.J. Neurol. 234, 44–51.
willemsen,r.,vandongen,j. m.,aerts,j. m. F. G.,schram,a. w.,tager,j. m.,goudsmit,r. &reuser,a. J. J. (1988) An immunoelectronmicroscopic study of glucocerebrosidase in type 1 Gaucher's disease spleen.Ultrastr. Pathol. 12, 471–8.
zimran,a.,elstein,d.,kannai,r.,zevin,s.,hadashalpern,l.,levy-lahad,e. &cohen,y. (1994) Low-dose enzyme replacement therapy for Gaucher disease: effets of age, sex, genotype and clinical features on reponse to treatment.Am. J. Med. 97, 3–13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Willemsen, R., Tibbe, J.J.M., Kroos, M.A. et al. A biochemical and immunocytochemical study on the targeting of alglucerase in murine liver. Histochem J 27, 639–646 (1995). https://doi.org/10.1007/BF02388464
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02388464